ICU Medical Inc
ICUI: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$971.00 | Gckr | Scbxdfjr |
ICU Medical: Reducing Our Moat Rating to None Due to Ongoing Smiths Integration Uncertainty
We are reducing ICU's moat rating to none, down from narrow, largely to account for uncertainty around the firm's economic profitability related to the Smiths acquisition. In conjunction, we have raised our Uncertainty Rating to High from Medium. The moat reduction shortens our modeled length of economic profitability, which brings our fair value estimate to $177 per share, down from $195 previously.